Mirvetuximab Soravtansine vs Osimertinib

## Mirvetuximab Soravtansine vs Osimertinib: Overview

This comparison examines the pharmacological differences between **Mirvetuximab Soravtansine** and **Osimertinib**.

## Mechanism of Action

**Osimertinib**: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

## Pharmacokinetics

**Half-life**: Mirvetuximab Soravtansine — N/A; Osimertinib — 48 hours.

## Chemical Properties

**Molecular Formula**: Mirvetuximab Soravtansine — N/A; Osimertinib — C28H33N7O2.

**Molecular Weight**: Mirvetuximab Soravtansine — N/A; Osimertinib — 499.6050 g/mol.

**Type**: Mirvetuximab Soravtansine — Antibody drug conjugate; Osimertinib — Small molecule.